CO95 A Matching-Adjusted Indirect Comparison of Filgotinib Versus Tofacitinib for Moderately to Severely Active Ulcerative Colitis
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.191
https://www.valueinhealthjournal.com/article/S1098-3015(22)00392-8/fulltext
Section Title :
Section Order :
10161
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00392-8&doi=10.1016/j.jval.2022.04.191